Insider · CIK 0001836254

Estepan Ian Michael

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001836254

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-04	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−24.8K sh	$22.22	−$551K	177,184
2026-03-11	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−1,097 sh	$17.03	−$18.7K	201,983
2026-03-09	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−1,036 sh	$16.95	−$17.6K	203,663
2026-03-09	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−583 sh	$16.95	−$9,881.85	203,080
2026-03-02	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−3,301 sh	$16.20	−$53.5K	205,574
2026-03-02	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−875 sh	$16.20	−$14.2K	204,699
2026-03-01	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+8,125 sh	—	—	208,875
2026-03-01	SRPTSarepta Therapeutics, Inc. · Performance Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−8,125 sh	—	—	0
2026-02-26	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,069 sh	$13.71	+$28.4K	195,369
2026-02-26	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,381 sh	$13.71	+$73.8K	200,750
2026-02-26	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−2,069 sh	—	—	0
2026-02-26	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,381 sh	—	—	0
2026-02-25	SRPTSarepta Therapeutics, Inc. · Performance Stock UnitsA Award	Chief Operating Officer	AAward	+1,875 sh	—	—	8,125
2025-12-16	SRPTSarepta Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−13.2K sh	$22.31	−$294K	193,300
2025-09-03	SRPTSarepta Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+93.9K sh	—	—	156,487
2025-09-03	SRPTSarepta Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+50K sh	—	—	206,487
2025-08-05	SRPTSarepta Therapeutics, Inc. · Performance Stock UnitsA Award	Chief Operating Officer	AAward	+6,250 sh	—	—	6,250
2025-03-10	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−1,051 sh	$100.13	−$105K	57,226
2025-03-10	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−2,890 sh	$100.13	−$289K	54,336
2025-03-10	SRPTSarepta Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+8,276 sh	—	—	62,612
2025-03-10	SRPTSarepta Therapeutics, Inc. · Stock Options (right to buy)A Award	Chief Operating Officer	AAward	+16.6K sh	—	—	16,644
2025-03-07	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−585 sh	$103.70	−$60.7K	61,871
2025-03-07	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−9,094 sh	$103.70	−$943K	52,777
2025-03-07	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,500 sh	—	—	58,277
2025-03-07	SRPTSarepta Therapeutics, Inc. · Performance Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,500 sh	—	—	0
2025-03-06	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+17.5K sh	—	—	62,456
2025-03-06	SRPTSarepta Therapeutics, Inc. · Performance Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−17.5K sh	—	—	0
2025-03-04	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−1,370 sh	$101.34	−$139K	44,956
2025-03-03	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−557 sh	$103.77	−$57.8K	46,326
2025-02-11	SRPTSarepta Therapeutics, Inc. · Performance Restricted Stock UnitsA Award	Chief Operating Officer	AAward	+3,500 sh	—	—	17,500
2025-01-29	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+14.3K sh	$12.00	+$171K	47,963
2025-01-29	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+1,533 sh	$12.00	+$18.4K	49,496
2025-01-29	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−2,613 sh	$117.51	−$307K	46,883
2025-01-29	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−14.3K sh	—	—	0
2025-01-29	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−1,533 sh	—	—	0
2024-12-27	SRPTSarepta Therapeutics, Inc.G Gift	Chief Operating Officer	GGift	−250 sh	—	—	33,696
2024-08-30	SRPTSarepta Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−5,985 sh	$137.36	−$822K	33,946
2024-06-24	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−2,483 sh	$164.64	−$409K	39,931
2024-06-21	SRPTSarepta Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+6,250 sh	—	—	42,414
2024-06-21	SRPTSarepta Therapeutics, Inc. · Performance Stock UnitsA Award	Chief Operating Officer	AAward	+5,500 sh	—	—	5,500
2024-06-21	SRPTSarepta Therapeutics, Inc. · Performance Stock UnitsA Award	Chief Operating Officer	AAward	+6,250 sh	—	—	6,250
2024-06-21	SRPTSarepta Therapeutics, Inc. · Performance Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−6,250 sh	—	—	0
2024-03-08	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−1,035 sh	$123.14	−$127K	36,164
2024-03-07	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−526 sh	$120.49	−$63.4K	37,199
2024-03-04	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−1,389 sh	$125.32	−$174K	37,725
2024-03-01	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−365 sh	$126.19	−$46.1K	34,314
2024-03-01	SRPTSarepta Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+6,000 sh	—	—	40,314
2024-03-01	SRPTSarepta Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−1,200 sh	$128.30	−$154K	39,114
2024-03-01	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	−12.5K sh	—	—	12,500
2023-03-08	SRPTSarepta Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−744 sh	$153.19	−$114K	34,679

Recent filings

Accepted (ET)
Sep 84
Estepan Ian Michael0001193125-26-385544
SEC(opens sec.gov)
Mar 134
Estepan Ian Michael0001193125-26-106710
SEC(opens sec.gov)
Mar 114
Estepan Ian Michael0001193125-26-102701
SEC(opens sec.gov)
Mar 34
Estepan Ian Michael0001193125-26-089432
SEC(opens sec.gov)
Mar 24
Estepan Ian Michael0001193125-26-084265
SEC(opens sec.gov)
Feb 274
Estepan Ian Michael0001193125-26-083674
SEC(opens sec.gov)
Dec 184
Estepan Ian Michael0001193125-25-325383
SEC(opens sec.gov)
Sep 54
Estepan Ian Michael0001193125-25-197423
SEC(opens sec.gov)
Aug 64
Estepan Ian Michael0000950170-25-104398
SEC(opens sec.gov)
Mar 114
Estepan Ian Michael0000950170-25-037519
SEC(opens sec.gov)

Companies

Sarepta Therapeutics, Inc.Chief Operating OfficerSRPT

Address

215 FIRST STREET SUITE 415

CAMBRIDGE, MA, 02142